Factor V Leiden and FII 20210 testing in thromboembolic disorders

被引：5

作者：

Pajic, Tadej ^{[1
]}

机构：

[1] Univ Med Ctr Ljubljana, Dept Haematol, Div Internal Med, Ljubljana, Slovenia

来源：

CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2010年 / 48卷

关键词：

Factor V Leiden; FII; 20210; quantitative real-time PCR; thromboembolic disorders; ACTIVATED PROTEIN-C; REAL-TIME PCR; POOR ANTICOAGULANT RESPONSE; VENOUS THROMBOEMBOLISM; PROTHROMBIN GENE; APC-RESISTANCE; INHERITED RESISTANCE; MULTIPLEX PCR; 3-UNTRANSLATED REGION; MOLECULAR-MECHANISMS;

D O I：

10.1515/CCLM.2010.372

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Factor V Leiden and prothrombin (F2) c.20210G>A mutation detection are very important in order to define the increased relative risk for venous thromboembolism in selected patients. Use of DNA-based methods to detect both mutations has become widely available in clinical diagnostic laboratories, including fluorescence-based quantitative real-time PCR (qPCR). The latter is a rapid, simple, robust and reliable method to identify genotypes of interest. There are several chemistries used for qPCR; this article describes their principles and applicability for Factor V Leiden and prothrombin (F2) c.20210G>A mutation detection. Clin Chem Lab Med 2010;48:S79-87.

引用

页码：S79 / S87

页数：9

共 50 条

[21] Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran
Bagheri, Morteza
Rad, Isa Abdi
Nanbakhsh, Fariba
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 284 (05) : 1311 - 1315
[22] Direct-to-consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
Elson, Sarah L.
Furlotte, Nicholas A.
Hromatka, Bethann S.
Wilson, Catherine H.
Mountain, Joanna L.
Rowbotham, Helen M.
Varga, Elizabeth A.
Francke, Uta
MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (11):
[23] Prevalence of factor V Leiden, FII G20210A, FXIII Va134Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis
Ramacciotti, E
Wolosker, N
Puech-Leao, P
Zeratti, EA
Gusson, PR
del Giglio, A
Franco, RF
THROMBOSIS RESEARCH, 2003, 109 (04) : 171 - 174
[24] Factor V Leiden and factor II G20210A mutations in patients with recurrent abortion
Souza, SS
Ferriani, RA
Pontes, AG
Zago, MA
Franco, RF
HUMAN REPRODUCTION, 1999, 14 (10) : 2448 - 2450
[25] Factor V Leiden: prevalence and thromboembolic complications after total hip replacement in Ireland
D. J. M. Bowler
E. Bale
J. O’Byrne
Irish Journal of Medical Science, 2007, 176 : 273 - 277
[26] Factor V Leiden: prevalence and thromboembolic complications after total hip replacement in Ireland
Bowler, D. J. M.
Bale, E.
O'Byrne, J.
IRISH JOURNAL OF MEDICAL SCIENCE, 2007, 176 (04) : 273 - 277
[27] The role of factor V Leiden and prothrombin G20210a mutations in sudden sensorineural hearing loss
Görür, K
Tuncer, T
Eskandari, G
Özcan, C
Ünal, M
Özsahinoglu, T
OTOLOGY & NEUROTOLOGY, 2005, 26 (04) : 599 - 601
[28] Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease
De Stefano, V
Zappacosta, B
Persichilli, S
Rossi, E
Casorelli, I
Paciaroni, K
Chiusolo, P
Leone, AM
Giardina, B
Leone, G
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) : 564 - 568
[29] Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation
Gouin-Thibault, I
Arkam, R
Nassiri, S
de la Tourette, A
Conard, J
Horellou, MH
Elalamy, I
Samama, MM
THROMBOSIS RESEARCH, 2002, 107 (1-2) : 7 - 11
[30] Mesenteric vein thrombosis in a patient heterozygous for factor V Leiden and G20210A prothrombin genotypes
Karmacharya, Paras
Aryal, Madan Raj
Donato, Anthony
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (43) : 7813 - 7815

← 1 2 3 4 5 →